Pluribus Labs’s Visa V Stock Holding History

Pluribus Labs’s Portfolio V Stock Details V Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,305	Closed	-$289K	–	92
2022 Q1	$289K	Sell	1,305 -925	-41%	-$200K	1.15%	27
2021 Q4	$483K	Buy	+2,230	New	+$479K	0.51%	54

Other funds holding V

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pluribus Labs's V Position: Q2 2022 in Review

Pluribus Labs sold out of Visa (V) in Q2 2022, closing a stake of 1,305 shares — an estimated $289K sold.

Pluribus Labs first reported a position in V in Q4 2021 and held it in 2 quarters. The position peaked at $483K in Q4 2021. 3,236 funds tracked by Wall St. Rank hold V as of Q2 2022.

Pluribus Labs reported no remaining Visa position as of Q2 2022 after selling out during the quarter.
Pluribus Labs sold 1,305 Visa shares in Q2 2022, an estimated $289K.
Pluribus Labs first reported a position in Visa in Q4 2021 and held it in 2 quarters.
Pluribus Labs's Visa position peaked at $483K in Q4 2021.
3,236 funds tracked by Wall St. Rank held Visa as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.